Healwell AI (AIDX) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached CAD 14.1 million, up 208% year-over-year, driven by organic growth and acquisitions.

• Net loss widened to CAD 14.1 million, impacted by higher operating expenses, Orion transaction costs, and stock-based compensation.

• Orion Health acquisition closed April 1, 2025, for CAD 144 million plus a CAD 20.6 million earn-out, expanding global reach and capabilities; results consolidated from Q2.

• Six strategic acquisitions completed in 19 months, raising over CAD 100 million in capital.

• Strategic leadership changes include James Lee as incoming CEO and new executive appointments to support integration and scale.

Financial highlights

• Q1 2025 revenue: CAD 14.1 million (Q1 2024: CAD 4.6 million), a 208% increase.

• Gross profit: CAD 6.5 million, up 226% year-over-year; gross margin at 46% (Q1 2024: 44–52%).

• Adjusted EBITDA loss: CAD 10.8 million (Q1 2024: loss of CAD 3.9 million), reflecting investments in scaling and higher marketing costs.

• Net loss: CAD 14.1 million, impacted by CAD 2.5 million in Orion transaction costs and CAD 2.9 million in stock-based compensation.

• Cash at quarter-end: CAD 18.4 million, with CAD 86.6 million in escrow for Orion acquisition.

Outlook and guidance

• Expecting healthy organic growth across all business units in 2025.

• Orion Health to add approximately CAD 100 million in annual revenue starting Q2 2025.

• Anticipate adjusted EBITDA positive for full year 2025, supported by cost optimization.

• Management expects positive cash flows and improved liquidity following Orion Health acquisition and cost reductions.

• The company anticipates meeting all obligations for at least the next twelve months, supported by new revenue streams and financing.